AAAAAA
Results: 1-25/98
Authors:
GRODZICKI T
MESSERLI FH
Citation: T. Grodzicki et Fh. Messerli, THE HEART IN THE HYPERTENSIVE ELDERLY, Journal of human hypertension, 12(9), 1998, pp. 593-597
Authors:
LIP GYH
LYDAKIS C
ZARIFIS J
MESSERLI FH
Citation: Gyh. Lip et al., REGRESSION OF LVH OR IMPROVED PROGNOSIS (OR BOTH) - WHAT IS THE QUESTION, Journal of human hypertension, 12(7), 1998, pp. 423-425
Authors:
KETELHUT RG
MESSERLI FH
SCHOLZE J
Citation: Rg. Ketelhut et al., DOES CARDIAC FATIGUE CAUSE A DECREASE IN ARTERIAL-PRESSURE DURING LONG-TERM AEROBIC EXERCISE, Perfusion, 11(7), 1998, pp. 301
Authors:
MESSERLI FH
Citation: Fh. Messerli, NIFEDIPINE AFTER ACUTE MYOCARDIAL-INFARCTION - SOLA DOSIS FACIT VENENUM - ONLY THE DOSE DETERMINES THE HARM, Cardiovascular drugs and therapy, 12(2), 1998, pp. 149-150
Authors:
GRODZICKI T
MICHALEWICZ L
MESSERLI FH
Citation: T. Grodzicki et al., AGING AND ESSENTIAL-HYPERTENSION - EFFECT OF LEFT-VENTRICULAR HYPERTROPHY ON CARDIAC-FUNCTION, American journal of hypertension, 11(4), 1998, pp. 425-429
Authors:
MESSERLI FH
GROSSMAN E
Citation: Fh. Messerli et E. Grossman, DO CALCIUM-ANTAGONISTS INCREASE THE RISK FOR MALIGNANCIES, Journal of the American College of Cardiology, 31(4), 1998, pp. 809-810
Authors:
NUNEZ E
NUNEZ JE
MICHALEWICZ L
MESSERLI FH
Citation: E. Nunez et al., GENDER DIFFERENCES IN HYPERTENSIVE TARGET ORGAN DISEASE, Journal of the American College of Cardiology, 31(2), 1998, pp. 522-522
Authors:
GROSSMAN E
MESSERLI FH
Citation: E. Grossman et Fh. Messerli, DOES DIURETIC THERAPY INCREASE THE RISK OF RENAL-CELL CARCINOMA IN WOMEN, Journal of hypertension, 16, 1998, pp. 83-83
Authors:
MESSERLI FH
MICHALEWICZ L
Citation: Fh. Messerli et L. Michalewicz, FIXED DRUG-COMBINATIONS IN THE TREATMENT OF HYPERTENSION - HOW TO IDENTIFY THE OPTIMAL DOSE, Journal of hypertension, 16, 1998, pp. 81-84
Authors:
GROSSMAN E
MESSERLI FH
Citation: E. Grossman et Fh. Messerli, EFFECT OF CALCIUM-ANTAGONISTS ON SYMPATHETIC ACTIVITY, European heart journal, 19, 1998, pp. 27-31
Authors:
MESSERLI FH
MITTLER BS
Citation: Fh. Messerli et Bs. Mittler, FRAMINGHAM AT 50, Lancet, 352(9133), 1998, pp. 1006-1006
Authors:
GROSSMAN E
IRONI AN
MESSERLI FH
Citation: E. Grossman et al., COMPARATIVE TOLERABILITY PROFILE OF HYPERTENSIVE CRISIS TREATMENTS, Drug safety, 19(2), 1998, pp. 99-122
Authors:
MESSERLI FH
GROSSMAN E
Citation: Fh. Messerli et E. Grossman, ANTIHYPERTENSIVE AGENTS AND THE RISK OF CANCER, JAMA, the journal of the American Medical Association, 280(7), 1998, pp. 600-600
Authors:
MESSERLI FH
GROSSMAN E
GOLDBOURT U
Citation: Fh. Messerli et al., ARE BETA-BLOCKERS EFFICACIOUS AS FIRST-LINE THERAPY FOR HYPERTENSION IN THE ELDERLY - A SYSTEMATIC REVIEW, JAMA, the journal of the American Medical Association, 279(23), 1998, pp. 1903-1907
Authors:
MESSERLI FH
Citation: Fh. Messerli, DIURETICS, BETA-BLOCKERS AND GIN-AND-TONIC, Medical journal of Australia, 169(6), 1998, pp. 344-344
Authors:
MESSERLI FH
GROSSMAN E
Citation: Fh. Messerli et E. Grossman, THE CALCIUM-ANTAGONIST CONTROVERSY - A POSTHUMOUS COMMENTARY, The American journal of cardiology, 82(9B), 1998, pp. 35-39
Authors:
LUCINI D
MILANI RV
VENTURA HO
MEHRA MR
MESSERLI FH
MURGO JP
REGENSTEIN F
COPLEY B
MALLIANI A
PAGANI M
Citation: D. Lucini et al., CYCLOSPORINE-INDUCED HYPERTENSION - EVIDENCE FOR MAINTAINED BAROREFLEX CIRCULATORY CONTROL, The Journal of heart and lung transplantation, 16(6), 1997, pp. 615-620
Authors:
AEPFELBACHER FC
MESSERLI FH
NUNEZ E
FROHLICH ED
Citation: Fc. Aepfelbacher et al., DISPARATE EFFECTS OF ACE-INHIBITORS AND CALCIUM-ANTAGONISTS ON LEFT-VENTRICULAR STRUCTURE AND FUNCTION IN ESSENTIAL-HYPERTENSION, Journal of human hypertension, 11(5), 1997, pp. 321-325
Authors:
BEEVERS DG
MESSERLI FH
UESHIMA H
Citation: Dg. Beevers et al., THE JOURNAL-OF-HUMAN-HYPERTENSION - LOOKING BACK OVER 10 YEARS OF RESEARCH AND THINKING OF THE FUTURE, Journal of human hypertension, 11(1), 1997, pp. 1-5
Authors:
BAKRIS GL
MESSERLI FH
Citation: Gl. Bakris et Fh. Messerli, THE LANAI-SYMPOSIUM - HYPERTENSIVE PATIENT PROFILES - APPROACHES TO MANAGEMENT AND DISEASE PREVENTION, Journal of human hypertension, 11(1), 1997, pp. 7-8
Authors:
MESSERLI FH
MICHALEWICZ L
Citation: Fh. Messerli et L. Michalewicz, EFFECTS OF COMBINATION THERAPY ON THE HEART, Journal of human hypertension, 11(1), 1997, pp. 29-33
Authors:
KETELHUT RG
MESSERLI FH
LOSEM C
FROHLICH ED
MICHALEWICZ L
Citation: Rg. Ketelhut et al., SYSTEMIC AND REGIONAL HEMODYNAMIC-EFFECTS OF GALLOPAMIL IN PATIENTS WITH ESSENTIAL-HYPERTENSION, Cardiovascular drugs and therapy, 11(1), 1997, pp. 39-42
Authors:
MESSERLI FH
GROSSMAN E
MICHALEWICZ L
Citation: Fh. Messerli et al., COMBINATION THERAPY AND TARGET ORGAN PROTECTION IN HYPERTENSION AND DIABETES-MELLITUS, American journal of hypertension, 10(9), 1997, pp. 198-201
Authors:
WEIDMANN PU
MESSERLI FH
KOHNER EM
MOGENSEN CE
RITZ E
BRETZEL RG
Citation: Pu. Weidmann et al., HYPERTENSION AND DIABETES-MELLITUS - A RISKY ALLIANCE - HOW CAN DRUG-THERAPY IMPROVE CLINICAL OUTCOME - (A PANEL DISCUSSION), American journal of hypertension, 10(9), 1997, pp. 218-219
Authors:
ROCKSTROH JK
SCHMIEDER RE
SCHLAICH MP
MESSERLI FH
Citation: Jk. Rockstroh et al., RENAL AND SYSTEMIC HEMODYNAMICS IN BLACK-AND-WHITE HYPERTENSIVE PATIENTS, American journal of hypertension, 10(9), 1997, pp. 971-978